EYEPOINT PHARMACEUTICALS INC (EYPT)
US30233G2093 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 36.94M 7.26% | 41.4M 12.07% | 46.018M 11.15% | 43.604M -5.25% | 15.72M -63.95% | 8.843M -43.75% | 56.972M 544.26% | 274.89M 382.50% | 531.15M 93.22% | 803.54M 51.28% | 1.032B 28.43% | |
| EBITDA YoY % growth | -52.51M -54.21% | -76.49M -45.67% | -74.603M 2.47% | 178.5M 339.27% | 209.1M 17.14% | 250.92M 20.00% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -55.28M -50.63% | -78.94M -42.80% | -75.067M 4.91% | -139.622M -86.00% | -193.895M -38.87% | -230.416M -18.84% | -193.137M 16.18% | -4.08M 97.89% | 195.98M 4,903.43% | 409.82M 109.11% | 590.8M 44.16% | |
| Operating Margin | -149.65% | -190.68% | -163.13% | -320.20% | -1,233.43% | -2,605.64% | -339.00% | -1.48% | 36.90% | 51.00% | 57.25% | |
| EPS YoY % growth | -2.02 40.59% | -2.73 -35.15% | -1.83 32.97% | -2.31 -26.20% | -2.72 -17.89% | -3.02 -10.90% | -2.18 27.70% | 0.77 135.33% | 3.25 321.16% | 5.61 72.86% | 8.61 53.39% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.54 -62.27% | -0.59 -6.45% | -0.60 -3.76% | -0.69 -26.93% | -0.71 -32.19% |
| Revenue Q2Q % growth | 10.865M -22.55% | 6.911M -40.85% | 6.732M -28.96% | 1.811M -82.79% | 1.862M -82.86% |
| EBITDA Q2Q % growth | 45.9M 388.86% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -29.617M -81.10% | -43.486M -30.51% | -44.778M -29.62% | -49.538M -51.27% | -51.17M -72.77% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.54 -63.64% | -0.57 | 0.03 | 4.90% |
| Q2 2024 Q2Q % growth | -0.58 4.92% | -0.54 | -0.04 | -8.31% |
| Q1 2024 Q2Q % growth | -0.55 1.79% | -0.42 | -0.13 | -29.62% |
| Q4 2023 Q2Q % growth | -0.33 71.55% | -0.50 | 0.17 | 33.44% |
| Q3 2023 Q2Q % growth | -0.33 32.65% | -0.52 | 0.19 | 36.92% |
| Q2 2023 Q2Q % growth | -0.61 -17.31% | 0.61 | -1.22 | -199.88% |
| Q1 2023 Q2Q % growth | -0.56 | -0.70 | 0.14 | 19.66% |
| Q4 2022 Q2Q % growth | -1.16 -96.61% | -0.62 | -0.54 | -86.44% |
| Q3 2022 Q2Q % growth | -0.49 15.52% | -0.71 | 0.22 | 30.98% |
| Q2 2022 Q2Q % growth | -0.52 -48.57% | -0.53 | 0.01 | 2.58% |
| Q1 2022 Q2Q % growth | -0.56 -12.00% | -0.59 | 0.03 | 5.01% |
| Q4 2021 Q2Q % growth | -0.59 41.00% | -0.55 | -0.04 | -8.12% |
| Q3 2021 Q2Q % growth | -0.58 -93.33% | -0.41 | -0.17 | -41.45% |
| Q2 2021 Q2Q % growth | -0.35 65.00% | -0.44 | 0.09 | 20.20% |
| Q1 2021 Q2Q % growth | -0.50 54.55% | -0.47 | -0.03 | -7.50% |
| Q4 2020 Q2Q % growth | -1.00 | -0.18 | -0.82 | -463.44% |
| Q3 2020 Q2Q % growth | -0.30 80.00% | -0.31 | 0.01 | 1.96% |
| Q2 2020 Q2Q % growth | -1.00 9.09% | -1.07 | 0.07 | 6.63% |
| Q1 2020 Q2Q % growth | -1.10 31.25% | -0.97 | -0.13 | -12.92% |
| Q4 2019 Q2Q % growth | -1.00 | -1.19 | 0.19 | 15.85% |
| Q3 2019 Q2Q % growth | -1.50 | -1.40 | -0.10 | -6.95% |
| Q2 2019 Q2Q % growth | -1.10 | -1.22 | 0.12 | 10.13% |
| Q1 2019 Q2Q % growth | -1.60 | -1.39 | -0.21 | -14.77% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 10.524M -30.77% | 10.276M | 248K | 2.41% |
| Q2 2024 Q2Q % growth | 9.477M 4.09% | 9.785M | -308K | -3.15% |
| Q1 2024 Q2Q % growth | 11.684M 52.08% | 10.185M | 1.499M | 14.72% |
| Q4 2023 Q2Q % growth | 14.028M 33.22% | 9.082M | 4.946M | 54.46% |
| Q3 2023 Q2Q % growth | 15.202M 51.87% | 7.676M | 7.526M | 98.05% |
| Q2 2023 Q2Q % growth | 9.105M -21.31% | 52.955M | -43.85M | -82.81% |
| Q1 2023 Q2Q % growth | 7.683M -17.30% | 7.577M | 106K | 1.40% |
| Q4 2022 Q2Q % growth | 10.53M -8.75% | 10.609M | -79K | -0.74% |
| Q3 2022 Q2Q % growth | 10.01M 10.49% | 10.857M | -847K | -7.80% |
| Q2 2022 Q2Q % growth | 11.57M 28.41% | 11.086M | 484K | 4.37% |
| Q1 2022 Q2Q % growth | 9.29M 26.91% | 10.085M | -795K | -7.88% |
| Q4 2021 Q2Q % growth | 11.54M 61.85% | 9.998M | 1.542M | 15.42% |
| Q3 2021 Q2Q % growth | 9.06M -42.29% | 10.039M | -979K | -9.75% |
| Q2 2021 Q2Q % growth | 9.01M 118.69% | 9.317M | -307K | -3.30% |
| Q1 2021 Q2Q % growth | 7.32M -2.27% | 8.085M | -765K | -9.46% |
| Q4 2020 Q2Q % growth | 7.13M -17.38% | 20.851M | -13.721M | -65.80% |
| Q3 2020 Q2Q % growth | 15.7M 525.50% | 13.579M | 2.121M | 15.62% |
| Q2 2020 Q2Q % growth | 4.12M -42.86% | 3.802M | 318K | 8.36% |
| Q1 2020 Q2Q % growth | 7.49M 272.64% | 7.399M | 91K | 1.23% |
| Q4 2019 Q2Q % growth | 8.63M | 7.319M | 1.311M | 17.91% |
| Q3 2019 Q2Q % growth | 2.51M | 4.013M | -1.503M | -37.45% |
| Q2 2019 Q2Q % growth | 7.21M | 6.826M | 384K | 5.63% |
| Q1 2019 Q2Q % growth | 2.01M | 3.457M | -1.447M | -41.86% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 18.94% | 0% | 4.02% |
| Revenue | 0% | 18.78% | 0% | 5.12% |